ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 101 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2014. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,053,000 | -18.1% | 57,314 | -4.5% | 0.01% | -20.0% |
| Q2 2017 | $3,728,000 | +13.8% | 60,023 | +24.2% | 0.02% | +15.4% |
| Q1 2017 | $3,276,000 | -5.6% | 48,338 | -2.1% | 0.01% | -7.1% |
| Q4 2016 | $3,472,000 | -0.5% | 49,387 | +0.4% | 0.01% | -6.7% |
| Q3 2016 | $3,490,000 | -8.1% | 49,200 | -36.6% | 0.02% | -6.2% |
| Q2 2016 | $3,796,000 | -31.7% | 77,610 | -11.2% | 0.02% | -33.3% |
| Q1 2016 | $5,555,000 | -39.1% | 87,371 | +7.5% | 0.02% | -38.5% |
| Q4 2015 | $9,121,000 | +13.5% | 81,305 | -2.5% | 0.04% | +8.3% |
| Q3 2015 | $8,033,000 | +5.9% | 83,410 | +12.5% | 0.04% | +16.1% |
| Q2 2015 | $7,589,000 | +110.6% | 74,119 | +27.7% | 0.03% | +106.7% |
| Q1 2015 | $3,604,000 | +55.9% | 58,050 | +10.2% | 0.02% | +50.0% |
| Q4 2014 | $2,312,000 | -12.3% | 52,699 | +13.2% | 0.01% | -9.1% |
| Q3 2014 | $2,635,000 | +234.4% | 46,547 | +165.1% | 0.01% | +266.7% |
| Q2 2014 | $788,000 | +59.2% | 17,555 | +73.2% | 0.00% | +50.0% |
| Q1 2014 | $495,000 | – | 10,133 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |